What We Do Publications 2007 Publications

  1. Balkau,B., Deanfield, J.E., Despres, J.P., Bassand, J.P., Fox, K.A., Smith, S.C. Jr, Barter, P., Tan, C.E., Van Gaal, L., Wittchen, H.U., Massien, C. and Haffner, S.M.(2007) International day for the evaluation of abdominal obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168, 000 primary care patients in 63 countries. Circulation 23;116(17): 1942-1951.
    View Abstract.

  2. Barter, P.J., Caulfield, M, Eriksson, M., Grundy, S.M., Kastelein, J.J., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.C., Waters, D.D., Shear, C.L., Revkin, J.H., Buhr, K.A., Fisher, M.R., Tall, A.R., Brewer, B; the ILLUMINATE Investigators. (2007) Effects of Torcetrapib in patients at high risk for coronary events. N Engl J Med.22:357(21): 2109-2122. View Abstract.

  3. Barter, P. Gotto, A.M., LaRosa, J.C., Maroni, J., Szarek, M., Kastelein J.J.P, Bittner, V., and Fruchart, J-C.(2007) For the treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol and cardiovascular events. N Engl J Med. 357; (13) 1301-1310. View Abstract.

  4. Barter, P., McPherson, Y.R., Song, K., Antero Kesaniemi, Y., Mahley, R., Waeber, G., Bersot, T., Mooser, V., Waterworth, D., and Grundy, S.M.,(2007)
    Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 92(6): 2041-2045. View Abstract.

  5. Barter, P.J., and Nicholls S.J.(2007) Current and emerging therapies in atheroprotection. In Mechanisms of vascular disease: a textbook for vascular surgeons. Fotridge, R and Thompson, M., Eds. Cambridge,
    pp 127-148. Abstract Unavailable.

  6. Barter, P.J., Puranik, R. and Rye, K.A. (2007) New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease. Curr Card Rep. (9) 493.498. View Abstract.

  7. Barter, P.J., and Rye, K.A. (2007) High-density lipoprotein structure and metabolism: regulation by cell membrane receptors. In The Year in Lipid Disorders. Packard C.J. and Wilkie, S., Eds. Oxford V 1, pp 93-112.

  8. Barter, P.J., and Rye, K.A., (2007) HDL and Atherosclerosis, In High-Density Lipoprotein, Fielding, C.J., ed., Wiley-Vch Verlag GmbH & Co, Weinheim, pp491-505. Abstract Unavailable.

  9. Brown, B.E., Rashid, I., van Reyk, D.M., and Davies, M.J.,(2007) Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. FEBS Lett. 1530-1541. View Abstract.

  10. Barter, P.J., and Shear, C.L. (2007) Aggressive management of obesity in children
    and young adults: the known challenges and potential opportunities.
    Clin Pharmacol Ther. 81(5): 627-630. View Abstract.

  11. Chandrasegaram, M.D., Celermajer, D.S., and Wilson, M.K.,(2007) Apical ballooning syndrome complicated by acute severe mitral regulation with left venticular outflow obstruction- Case report. J Cardiothorac Surg. 21;2:14. View Abstract.

  12. Chatterjee, S., Jarvis-Kay, J., Rengarajan, T., Lawrence, I.G, McNally, P.G., and Davies, M.J. (2007) Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study. Diabetes Res Clin Pract. 77(2):215-222. View Abstract.

  13. Chow, C., Cardona, M., Raju, P.K., Iyengar, S., Sukumar, A., Raju, R., Colman, P., Madhav, P. Raju, R., Srinath Reddy, K., Celermajer, D., Neal, B.,(2007) Cardiovascular disease and risk factors among 345 adults in rural India-the Andhra Pradesh Rural Health Initiative. Int J Cardiol. 116(2):180-185. View Abstract.

  14. Cohn, J.S.,(2007) Lipid metabolism and metabolic disease: Defining new targets. Curr Opin Lipidol. 18(3): 237-239. Abstract Unavailable.

  15. De Ciuceis, C., Amiri, F., Iglarz, M., Cohn, J.S., Touyz, R.M., Schiffrin, E.L.,
    (2007) Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin ll-induced hypertension in rats. Br J Pharmacol 151(1): 45-53. View Abstract.

  16. Dremina, E.S., Sharov, V.S., Davies, M.J., and Schoneich, C.(2007) Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem Res Toxicol. 20(10):1462-1469. View Abstract.

  17. Glaros, E.N., Kim, W.S.,Wu, B.J., Suarna, C., Quinn, C.M., Rye, K.A., Stocker, R., Jessup, W., and Garner, B.,(2007) Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochem Pharmacol 73(9):1340-1346. View Abstract.

  18. Gracanin, M., and Davies, M.J. (2007) Inhibition of protein tyrosine phosphatases by amino acid, peptide, and protein hydroperoxides: Potential modulation of cell signaling by protein oxidation products. Free Radic Biol Med. 42(10): 1543-1551. View Abstract.

  19. Hawkins, C.L., Pattison, D.I., Whiteman, M. and Davies, M.J.(2007) Chlorination and nitration of DNA and nucleic acid components. In 'Oxidative Damage to nucleic acids', (Cooke, M.S., and Evans, M.D., eds) Chapter 2. Springer, New York. Abstract Unavailable.

  20. Hennessy, A., Thornton, C.E., Makris, A., Ogle, R.F., Henderson-Smart, D.J., Gillin, A.G., and Child, A. (2007) A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: The PIVOT trial. Aust N Z J Obstet Gynaecol. 47(4):279-285. View Abstract.

  21. Kastelein, J.J., van Leuven, S.,I., Burgess, L., Evans, G.W., Kuivenhoven, J.A., Barter, P.J., Revkin, J.,H., Grobbee, D.E., Riley, W.A., Shear, C.L.,Duggan, W.T., and Bots, M.L.,(2007) Effect of Torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
    N Engl J Med. 356(16): 1620-1630. View Abstract.

  22. Kennett, E.,C., and Davies M.,J., (2007) Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: Evidence for a hydroxyl-radical-like mechanism. Free Radic Biol Med 42(8): 1278-1289. View Abstract.

  23. Kim, W.S., Rahmanto, A.S., Kamili, A., Rye, K.A., Guillemin, G.J., Gelissen, I.C., Jessup, W., Hill, A.F., Garner, B. (2007) Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem. 2:282(5):2851-2861. View Abstract.

  24. Lambert, G., (2007) Unravelling the functional significance of PCSK9.
    Curr Opin Lipidol. 18(3):304-309. View Abstract.

  25. Levy, M., Maurey, C., Celermajer, D.S., Vouche, P.R., Danel, C., Bonnet, D., and Israel-Biet, D. (2007) Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J. AM. Coll. Cardiol. 49(7): 803-810.

  26. Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., Mckenzie, P., Kirwan, P., Hennessy, A.(2007) Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 71(10): 977-984. View Abstract.

  27. Makris, A., Thornton, C., Thompson, J., Martin, R., Ogle, R., Waugh, R., Mckenzie, P., Kirwan, P. and Hennessy, A.(2007) Uteroplacental ishcemia results in an increase in soluble FLT-1 and Endoglin. J Paediatr Child Health. 43:A116. No Abstract Available.

  28. Maple-Brown, L., Cunningham, J., Celermajer, D.S., and O'Dea, K (2007) Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clin Endocrinol. (Oxf) 66(3): 419-425.
    View Abstract.

  29. Maple-Brown, L.J., Piers, L.S., O'Rourke, M.F., Celermajer, D.S., and O'Dea, K.,(2007) Increased arterial stiffness in remote indigenous Australians with high risk of cardiovascular disease. J. Hypertension.(3):585-591. View Abstract.

  30. Marijion, E., Trinquart, L., Jani, D., Jourdier, H., Garbarz, E., Mocumbi, A.O., Celermajer, D.S., and Ferreria, B. (2007) Coronary Heart disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 21(5):411-414. Abstract Unavailable.

  31. Matsuo, Y., Miura, S.I., Kawamura, A., Uehara, Y., Rye, K.A., Saku, K.,(2007) Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis 194(1): 159-168. View Abstract.

  32. Morgan, P.E., Sturgess, A.D., Hennessy, A., and Davies M.J. (2007) Serum protein oxidation and apolipoprotein Clll levels in people with systemic lupus erythematosus with and without nephritis. Free Radic Res 41(12):1301-1312. View Abstract.

  33. Ng, T.W., Watts, G.F., Barrett, P.H., Rye, K.A., and Chan, D.C.(2007) Effect of wieght loss on LDL and HDL kinetics in the metabolic syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care. 30(11):2945-2950.
    View Abstract.

  34. Nobecourt, E. Davies, M.J., Brown, B.E., Curtiss, L.K., Bonnet, D.J., Charlton, F., Januszeski, A.S., Jenkins, A.J., Barter, P.J., and Rye, K.A.,(2007) The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin: cholesterol acyltransferase. Diabetologia. 50:(3):643-653. View Abstract.

  35. Nunn, A.V., Bell, J., and Barter, P.,(2007) The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance.
    Nucl Recept. 25;5(1):1. View Abstract.

  36. Ooi, E.M, Chan, D.C., Rye, K.A., and Watts, G.F.,(2007) Differences in plasma PLTP activity assays: constant or random error?
    Clin Endocrinol (OXF) 67(2):3.17. No Abstract available.

  37. Ou, P., Celermajer, D.S., Agnoletti, G., Brunelle, F., Vouche, P., Sidi, D., and Bonnet, D.,(2007) Images in cardiovascular medicine. Definitive diagnosis of pulmonary artery sling in a critically ill infant with high resolution computed tomography (CT).
    Circulation. 114(25): e646-647. Abstract Unavailable.

  38. Ou, P., Celermajer, D.S., Calcagni, G., Brunelle, F., Bonnet, D., and Sidi, D.,(2007) Three-dimensional CT scanning: a new diagnostic modality in congenital heart disease.
    Heart 93(8):9008-913. View Abstract.

  39. Ou, P., Celermajer, D.S.,Mousseaux, E., Giron, A., Aggoun, Y., Szezepanski, I., Sidi, D., Bonnet, D.(2007) Vascular remodeling after "successful" repair of coarctation: impact of aortic arch geometry.
    J AM Coll Cardiol. 49(8):883-890. View Abstract.

  40. Patel, S., Harmer, J.A., Loughnan, G., Skilton, M.R., Steinbeck, K., and Celermajer, D.S., (2007) Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clin. Endocrinol. 66(6): 771-777. Abstract Unavailable.

  41. Pattison, D.I., Hawkins, C.L., and Davies, M.J. (2007) Hypochlorous Acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure? Biochemistry, 46(34):9853-9864. View Abstract.

  42. Puranik, R., Greaves, K., Hawker, R.E., Pressley, L.A., Robinson, P.J., and Celermajer, D.S. (2007) Abnormal right ventricular tissue velocities after repair of congenital heart disease-implcations for late outcomes.
    Heart Lung Circ. 16(4): 295-299. View Abstract.

  43. Rashid, I., van Reyk, D.M., and Davies, M.J.(2007) Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett. 581:1067-1070. View Abstract.

  44. Rees, M.D., McNiven, T.N., and Davies, M.J.,(2007) Degradation of extracellular matrix and its components by hypobromous acid.
    Biochem. J. 401(2): 587-596. View Abstract.

  45. Siggins, S., Rye, K.A., Olkkonen, V.M., Jauhianen, M., and Ehnholm, C. (2007) Human plasma phospholipid transfer protein (PLTP)- Structural and functional features, In High-Density Lipoproteins, Fielding, C.J., ed., Wiley-Vch Verlag GmbH & Co, Weinheim, pp 183-205.
    Abstract Unavailable.

  46. Skaff, O., Pattison, D.I. and Davies, M.J.(2007) Kinetics of hypobromous acid-mediated oxidation of lipid components and antioxidants. Chem Res Toxicol. 20(12):1980-1988. View Abstract.

  47. Skropeta, D., Settasatian, C., McMahon, M.R., Shearston, K.D, Caiazza, D., McGrath, K.C., Jim, W., Rader,D.J., Barter, P.J., and Rye, K.A., (2007) N-glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-l-containing high density lipoproteins. J Lipid Res. 48(9):2047-2057. View Abstract.

  48. Sumi, M., Sata, M., Miura, S.L., Rye, K.A., Toya, N., Kanaoka, Y., Yanaga, K., Ohki, T., Saku, K., Nagai, R., (2007) Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis.
    Arterioscler Thromb Vasc Biol. 27(4):813-818. View Abstract.

  49. Thanyasiri, P., Celermajer, D.S., Kathir, K., and Adams, M.R.,(2007) Endothelial dysfunction and restenosis following percutaneous coronary intervention. Ini J Cardiol 119(3):362-367. View Abstract.

  50. Thornton, C., Hennessy, A., von Dadelszen, P., Makris, A., Ogle, R., (2007) International benchmarking- would it make you change your clinical practice? JPC 43:s1, A138. Abstract Unavailable.

  51. Thornton, C., Hennessy, A., von Dadelszen P., Nishi, C., Markis, A., Ogle, R. (2007) An international benchmarking collaboration: Measuring outcomes for the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 29(10):794-800. View Abstract.

  52. Zhang, B., Uehara, Y., Hida, S., Miura, S.I., Rainwater, D.L., Segawa, M., Kumagai, K., Rye, K.A, Saku, K., (2007) Effects of apoA-I/phosphatidylcholine discs on charge-based LDL subfractions as characterised by capillary isotachophoresis. J. Lipid Res.
    48(5): 1175-1189. View Abstract.
donate now

Subscribe to our newsletter

:

: